Table 9.
Scenario analysis: time horizon
| FDC tablet solifenacin 6 mg + TOCAS vs tolterodine + tamsulosin | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
| Cost difference* (£) | −99 | 26 | 223 | 404 |
| QALY difference* | 0.002 | 0.011 | 0.017 | 0.018 |
| ICER*‡ | Dominant (−£40,469) | £2,351 | £13,531 | £22,224 |
*Per patient.
‡FDC tablet solifenacin 6 mg + TOCAS versus tolterodine + tamsulosin.
FDC, fixed-dose combination; ICER, incremental cost effectiveness ratio; QALY, quality of life adjusted years; TOCAS, oral controlled absorption system (OCAS™) formulation of tamsulosin.